Principal Financial Group Inc. increased its position in shares of Hill-Rom Holdings Inc. (NYSE:HRC) by 14.6% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 219,794 shares of the medical technology company’s stock after buying an additional 27,989 shares during the period. Principal Financial Group Inc. owned approximately 0.34% of Hill-Rom Holdings worth $11,088,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Aperio Group LLC boosted its position in Hill-Rom Holdings by 11.1% in the first quarter. Aperio Group LLC now owns 12,062 shares of the medical technology company’s stock worth $607,000 after buying an additional 1,207 shares during the last quarter. Pacad Investment Ltd. bought a new position in Hill-Rom Holdings during the first quarter worth approximately $337,000. TIAA CREF Investment Management LLC boosted its position in Hill-Rom Holdings by 107.2% in the first quarter. TIAA CREF Investment Management LLC now owns 273,081 shares of the medical technology company’s stock worth $13,736,000 after buying an additional 141,282 shares during the last quarter. Teachers Advisors Inc. boosted its position in Hill-Rom Holdings by 9.2% in the first quarter. Teachers Advisors Inc. now owns 323,425 shares of the medical technology company’s stock worth $16,268,000 after buying an additional 27,243 shares during the last quarter. Finally, BlackRock Inc. boosted its position in Hill-Rom Holdings by 18.5% in the first quarter. BlackRock Inc. now owns 24,859 shares of the medical technology company’s stock worth $1,250,000 after buying an additional 3,877 shares during the last quarter. 83.11% of the stock is currently owned by institutional investors.
Shares of Hill-Rom Holdings Inc. (NYSE:HRC) opened at 59.76 on Thursday. The firm has a market cap of $3.91 billion, a PE ratio of 61.54 and a beta of 1.14. The stock’s 50 day moving average is $60.09 and its 200 day moving average is $53.73. Hill-Rom Holdings Inc. has a 12 month low of $42.99 and a 12 month high of $63.12.
Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings data on Thursday, August 4th. The medical technology company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.76 by $0.05. The firm earned $655.40 million during the quarter, compared to analysts’ expectations of $647.75 million. Hill-Rom Holdings had a return on equity of 16.62% and a net margin of 2.47%. The firm’s quarterly revenue was up 38.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.62 EPS. On average, analysts anticipate that Hill-Rom Holdings Inc. will post $3.33 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 30th. Investors of record on Friday, September 16th were given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend was Wednesday, September 14th. Hill-Rom Holdings’s dividend payout ratio is presently 73.91%.
HRC has been the topic of a number of recent analyst reports. Morgan Stanley raised shares of Hill-Rom Holdings from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $54.00 to $62.00 in a research report on Thursday, June 16th. KeyCorp reaffirmed a “buy” rating and issued a $59.00 target price on shares of Hill-Rom Holdings in a research report on Thursday, June 23rd. Finally, Zacks Investment Research raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $64.00 target price on the stock in a research report on Tuesday, August 9th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $62.20.
Hill-Rom Holdings Company Profile